Literature DB >> 14601051

Expression of TGF-beta type II receptor antisense RNA impairs TGF-beta signaling in vitro and promotes mammary gland differentiation in vivo.

Anne E G Lenferink1, Joanne Magoon, Marie-Claude Pepin, Alain Guimond, Maureen D O'Connor-McCourt.   

Abstract

In order to clarify the role of TGF-beta in mammary development and tumorigenesis, we investigated the efficacy of full- or partial-length TbetaRII antisense RNA specifically to reduce TbetaRII levels in both in vitro and in vivo model systems. Here we show that the expression of TbetaRII antisense RNA in vitro reduced TbetaRII cell surface expression and inhibited the antiproliferative and transcriptional responses to exogenous TGF-beta. Expression of full-length TbetaRII antisense RNA in a transgenic mouse model under control of the mouse mammary tumor virus promotor resulted in precocious lobuloalveolar development of the mammary gland, a phenotype that resembles that of early pregnancy. These data demonstrate that TbetaRII plays a critical role in maintaining the nondifferentiated character of virgin mammary gland epithelium. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14601051     DOI: 10.1002/ijc.11494

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  9 in total

1.  Choreographing metastasis to the tune of LTBP.

Authors:  Anupama Chandramouli; Julia Simundza; Alicia Pinderhughes; Pamela Cowin
Journal:  J Mammary Gland Biol Neoplasia       Date:  2011-04-15       Impact factor: 2.673

Review 2.  Molecular mechanisms of head and neck cancer.

Authors:  Amit M Deshpande; David T Wong
Journal:  Expert Rev Anticancer Ther       Date:  2008-05       Impact factor: 4.512

3.  TGF-β in the Bone Microenvironment: Role in Breast Cancer Metastases.

Authors:  Jeroen T Buijs; Keith R Stayrook; Theresa A Guise
Journal:  Cancer Microenviron       Date:  2011-07-12

4.  Transforming growth factor-beta regulator SnoN modulates mammary gland branching morphogenesis, postlactational involution, and mammary tumorigenesis.

Authors:  Nadine S Jahchan; Young-Hyun You; William J Muller; Kunxin Luo
Journal:  Cancer Res       Date:  2010-05-11       Impact factor: 12.701

Review 5.  Transforming growth factor beta (TGF-beta) and inflammation in cancer.

Authors:  Brian Bierie; Harold L Moses
Journal:  Cytokine Growth Factor Rev       Date:  2009-12-16       Impact factor: 7.638

Review 6.  Transforming growth factor-beta signaling: emerging stem cell target in metastatic breast cancer?

Authors:  Antoinette R Tan; Gabriela Alexe; Michael Reiss
Journal:  Breast Cancer Res Treat       Date:  2008-10-09       Impact factor: 4.872

Review 7.  The Role of TGF-β in Bone Metastases.

Authors:  Trupti Trivedi; Gabriel M Pagnotti; Theresa A Guise; Khalid S Mohammad
Journal:  Biomolecules       Date:  2021-11-06

8.  Investigation of three new mouse mammary tumor cell lines as models for transforming growth factor (TGF)-beta and Neu pathway signaling studies: identification of a novel model for TGF-beta-induced epithelial-to-mesenchymal transition.

Authors:  Anne E G Lenferink; Joanne Magoon; Christiane Cantin; Maureen D O'Connor-McCourt
Journal:  Breast Cancer Res       Date:  2004-07-06       Impact factor: 6.466

9.  Role of TGF-β in breast cancer bone metastases.

Authors:  Antonella Chiechi; David L Waning; Keith R Stayrook; Jeroen T Buijs; Theresa A Guise; Khalid S Mohammad
Journal:  Adv Biosci Biotechnol       Date:  2013-10-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.